HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Next Previous
Trial Profile

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Feb 2018

At a glance

  • Drugs Sofosbuvir (Primary)
  • Indications Hepatitis E
  • Focus Therapeutic Use
  • Acronyms HepNet Pilot Trial; HepNet-SofE study

    • Most Recent Events

    • 05 Feb 2018 Last checked against European Clinical Trials Database record.
    • 04 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
    • 04 Dec 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top